Moonshots with Peter Diamandis

Podbit · Moonshots with Peter Diamandis

Michael Kratsios on the New Golden Age of American Science | EP #276

Explore episode Aug 4, 2026
Science
Golden Tickets: How to Fund Crazy Ideas Without Losing Accountability

Michael Kratsios on the New Golden Age of American Science … · Aug 4, 2026 Science

Each reviewer on a grant panel gets 1–3 golden tickets, allowing them to unilaterally fund a proposal regardless of what the rest of the committee thinks. This does two things: it incentivizes bolder proposals from applicants and attracts higher-quality reviewers who want the power of a golden ticket.

Where this was said

Reforming Science Funding: Long-Duration Grants, Fast Grants, and Meta-Science

At 39:50 · chapter starts 37:30

Peter walks Kratsios through the specific mechanisms in the Golden Age Report for reforming scientific funding. First: long-duration grants — most government grants are roughly 18 months, not because that's the right timeline for discovery but because it's administratively convenient. Some ideas need 5 years to properly explore. Second: fast grants — inspired by Tyler Cowen and others who pooled private capital during COVID to make grant decisions in hours rather than months, with no reason this model should be restricted to emergencies. Third and most structurally important: meta-science units — new departments at NIH and NSF dedicated to empirically evaluating whether funding mechanisms themselves are working and course-correcting when they're not. Kratsios notes that government essentially never runs experiments on its own funding processes, and the meta-science units — already announced at NIH and NSF — are the first step toward treating science funding as a system that can itself be optimized.

Similar podbits

Science
The Placebo Effect Is Not Fake — It Just Belongs to the Story, Not the Drug

#403 ‒ Peptides: separating scientific promise from marketi… · Aug 10, 2026 Science

Peptides come loaded with a powerful narrative: regenerative, subcutaneous, targeted, cutting-edge. That narrative can genuinely move outcomes, especially for pain, energy, and recovery. The RCT's job is to quantify how much additional benefit comes from the molecule itself — above and beyond the compelling story surrounding it.